Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
24.58
-0.50 (-1.99%)
At close: Jun 15, 2026, 4:00 PM EDT
24.00
-0.58 (-2.36%)
After-hours: Jun 15, 2026, 6:07 PM EDT

Genmab Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of $36.82. The average 1-year stock price forecast is 49.80% higher than the current stock price, while the lowest is $32 (+30.19%) and the highest is $41.5 (+68.84%).

Price Target: $36.82 (+49.80%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$32$36.82$38$41.5
Change+30.19%+49.80%+54.60%+68.84%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy668999
Buy000000
Hold233222
Sell000000
Strong Sell000000
Total8911111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Reiterates
$65$40
BuyReiterates$65$40+62.73%Jun 2, 2026
Truist Financial
Truist Financial
Buy
Initiates
$48$40
BuyInitiates$48$40+62.73%May 27, 2026
Guggenheim
Guggenheim
Buy
Maintains
$40
BuyMaintains$40+62.73%May 26, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 19, 2026
TD Cowen
TD Cowen
Hold
Maintains
$32
HoldMaintains$32+30.19%May 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.38B
from 3.72B
Increased by 17.65%
Revenue Next Year
5.13B
from 4.38B
Increased by 17.25%
EPS This Year
1.17
from 1.77
Decreased by -34.18%
EPS Next Year
1.67
from 1.17
Increased by 43.59%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Jan 1, 2024Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.29B2.08B2.39B3.12B3.72B4.38B
Revenue Growth
-22.52%61.88%14.68%30.59%19.19%17.65%
Gross Profit
1.29B2.08B2.36B2.98B3.48B4.09B
Gross Margin
100.00%100.00%98.62%95.42%93.60%93.53%
Operating Income
451.68M900.43M772.00M1.02B1.25B1.19B
Net Income
452.29M783.33M631.00M1.13B963.00M746.00M
EPS
----1.771.17
EPS Growth
-----10.69%-34.18%
Forward PE
-----21.07
Free Cash Flow
259.80M305.10M777.92M915.13M1.07B974.38M
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.7B
Avg4.4B
Low4.2B

Revenue Growth

Revenue Growth202620272028
High
26.5%
Avg
17.7%
Low
13.6%

EPS Forecast

EPS202620272028
High1.71
Avg1.17
Low0.91

EPS Growth

EPS Growth202620272028
High
-3.3%
Avg
-34.2%
Low
-48.8%